Financials

v3.6.0.2
CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($)
Dec. 31, 2016
Sep. 30, 2016
Current assets:    
Cash $ 220,438 $ 3,103
Accounts receivable, net 12,019 24,000
Inventory 10,267 9,585
Prepaid expenses and other current assets 7,012 16,115
Total current assets 249,736 52,803
Other assets:    
Other assets 8,656 8,656
Licensing agreement (net of amortization) 240,332
Collabria customer base (net of amortization) 92,613
ReadyOp software platform (net of amortization) 190,167
Total other assets 291,436 248,988
Total assets 541,172 301,791
Current liabilities:    
Accounts payable 436,254 434,360
Accrued expenses 54,400 35,347
Deferred revenue, current portion 93,248 47,652
Notes payable - stockholders 118,006
Total current liabilities 701,908 517,359
Long Term Liabilities    
Notes payable - stockholders 132,676
Deferred revenue, net of current portion 2,495 2,962
Total long term liabilities 2,495 135,638
Total liabilities 704,403 652,997
Stockholders' deficit:    
Common stock - $.00001 par value; 5,000,000,000 shares authorized, 203,899,190 shares issued and outstanding, respectively. 2,039 2,039
Additional paid-in capital 14,854,319 14,299,242
Accumulated Deficit (15,019,658) (14,652,520)
Total stockholders' equity (deficit) (163,231) (351,206)
Total liabilities and stockholders' deficit 541,172 301,791
Series A Preferred Stock [Member]    
Stockholders' deficit:    
Preferred stock 6
Series B Preferred Stock [Member]    
Stockholders' deficit:    
Preferred stock
Series C Preferred Stock [Member]    
Stockholders' deficit:    
Preferred stock 26 26
Series D Preferred Stock [Member]    
Stockholders' deficit:    
Preferred stock 7 7
Series E Preferred Stock [Member]    
Stockholders' deficit:    
Preferred stock $ 30
v3.6.0.2
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)
3 Months Ended
Dec. 31, 2016
Dec. 31, 2015
Revenue $ 100,000 $ 90,994
Cost of Revenue 37,522 40,380
Gross Profit 62,478 50,613
Operating Expenses:    
Selling expenses 37,216 13,312
Administrative expenses 118,730 52,230
Amortization and depreciation 249,792 35,167
Research and development 18,700
Total operating expenses 424,438 100,709
Loss from operations (361,960) (50,096)
Other Income (Expense)    
Interest and other expenses (5,178) (37,514)
Total Other Income (Expense) (5,178) (37,514)
Net loss (367,138) (87,610)
Total preferred stock dividens (4,394)
Net loss attributable to common stockholders $ (371,532) $ (87,610)
Loss per common share - basic and diluted $ 0.00 $ 0.00
Weighted average number of shares outstanding: Basic and diluted 203,899,190 197,619,926
Series A Preferred Stock [Member]    
Other Income (Expense)    
Preferred stock dividens Series A Preferred $ (4,394)
v3.6.0.2
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
3 Months Ended
Dec. 31, 2016
Dec. 31, 2015
Statement of Cash Flows [Abstract]    
NET (LOSS) $ (367,138) $ (87,610)
Adjustments to reconcile net loss to net cash used in operating activities:    
Amortization of license agreement 240,332 35,167
Amortization of Collabria client list 4,027
Amortization of ReadyOp software platform 5,433
Premium on convertible debt 2,500
Amortization of debt discount 14,631
(Increase) decrease in assets:    
Accounts receivable 11,981 61,017
Inventory (681) (5,026)
Prepaid expenses and other current assets 9,103 (23,200)
Increase (decrease) in liabilities:    
Accounts payable 1,893 (36,732)
Accrued expenses 19,383 (6,190)
Deferred revenue 45,129 8,235
Net Cash Used in Operating Activities (30,538) (37,208)
Cash Flows From Financing Activities:    
Proceeds from note payable 50,000
Principal payments on notes payable (15,000) (36,581)
Proceeds from issuance of common stock 5,000
Proceeds from issuance of Convertible Preferred stock 262,873  
Proceeds from convertible note payable 25,000
Net Cash Provided by Financing Activities 247,873 43,419
Net Increase in Cash 217,335 6,211
Cash - Beginning of Period 3,103 6,156
Cash - End of Period 220,438 12,367
SUPPLEMENTAL CASH FLOW INFORMATION:    
Cash paid for interest 1,214 1,193
Cash paid for taxes